Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
42.52 USD | +2.93% | -1.33% | -29.10% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.10% | 5.01B | |
-3.05% | 90.45B | |
+3.95% | 41.45B | |
-10.70% | 33.57B | |
+60.58% | 25.73B | |
-20.74% | 14.73B | |
-9.13% | 12.82B | |
-11.46% | 11.7B | |
-43.05% | 11.44B | |
+5.17% | 8.79B |
- Stock Market
- Equities
- APLS Stock
- News Apellis Pharmaceuticals, Inc.
- Credit Suisse Raises Apellis Pharmaceuticals' PT to $44 from $40, Says On Track to Submit NDA for Pegcetacoplan in Q2; Keeps Neutral Rating